TWI857027B - 心肌肌鈣蛋白活化劑之多晶型物 - Google Patents

心肌肌鈣蛋白活化劑之多晶型物 Download PDF

Info

Publication number
TWI857027B
TWI857027B TW109108225A TW109108225A TWI857027B TW I857027 B TWI857027 B TW I857027B TW 109108225 A TW109108225 A TW 109108225A TW 109108225 A TW109108225 A TW 109108225A TW I857027 B TWI857027 B TW I857027B
Authority
TW
Taiwan
Prior art keywords
peaks
xrpd
radiation
compound
further characterized
Prior art date
Application number
TW109108225A
Other languages
English (en)
Chinese (zh)
Other versions
TW202100517A (zh
Inventor
史蒂芬妮 阿扎里
瑪莉 查維茲
賈斯汀 馬利諾瓦斯基
史蒂芬 M 曼寧
戴倫 L 里德
Original Assignee
美商安進公司
美商賽托基尼提克斯公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商安進公司, 美商賽托基尼提克斯公司 filed Critical 美商安進公司
Publication of TW202100517A publication Critical patent/TW202100517A/zh
Application granted granted Critical
Publication of TWI857027B publication Critical patent/TWI857027B/zh

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW109108225A 2019-03-12 2020-03-12 心肌肌鈣蛋白活化劑之多晶型物 TWI857027B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962817194P 2019-03-12 2019-03-12
US62/817,194 2019-03-12

Publications (2)

Publication Number Publication Date
TW202100517A TW202100517A (zh) 2021-01-01
TWI857027B true TWI857027B (zh) 2024-10-01

Family

ID=70190163

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109108225A TWI857027B (zh) 2019-03-12 2020-03-12 心肌肌鈣蛋白活化劑之多晶型物

Country Status (6)

Country Link
US (1) US20220185791A1 (cg-RX-API-DMAC7.html)
EP (1) EP3938042A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022525102A (cg-RX-API-DMAC7.html)
CN (1) CN114025845A (cg-RX-API-DMAC7.html)
TW (1) TWI857027B (cg-RX-API-DMAC7.html)
WO (1) WO2020185983A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004800A2 (pt) 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos
SG11202109891WA (en) 2019-03-12 2021-10-28 Amgen Inc Polymorphs and cocrystals of a cardiac troponin activator
EP4308095A4 (en) 2021-03-15 2025-02-19 Maze Therapeutics, Inc. GLYCOGEN SYNTHASE 1 (GYS1) INHIBITORS AND METHODS OF USE THEREOF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU3192500A (en) * 1999-03-16 2000-10-04 C & C Research Laboratories Substituted proline derivatives and medicinal compositions containing the same
TW200911787A (en) * 2007-07-03 2009-03-16 Astrazeneca Ab New aza-bicyclohexane compounds useful as inhibitors of thrombin
EP3821882A1 (en) * 2013-03-14 2021-05-19 Amgen Inc. Heterocyclic compounds and their uses
BR112020004800A2 (pt) * 2017-09-13 2020-09-24 Amgen Inc. compostos de bisamida ativantes do sarcômero e seus usos

Also Published As

Publication number Publication date
WO2020185983A1 (en) 2020-09-17
CN114025845A (zh) 2022-02-08
EP3938042A1 (en) 2022-01-19
JP2022525102A (ja) 2022-05-11
US20220185791A1 (en) 2022-06-16
TW202100517A (zh) 2021-01-01

Similar Documents

Publication Publication Date Title
US12612366B2 (en) Salts and crystal forms of omecamtiv mecarbil
EP3443960A1 (en) Crystalline form of trisodium supramolecular complex comprising valsartan and ahu-377 and methods thereof
US20250367186A1 (en) C-Met Modulator Pharmaceutical Compositions
CN114008024A (zh) 具有铁死亡诱导活性的化合物以及使用其的方法
CN117417263A (zh) Rad1901-2hcl的多晶型形式
EP3233809A1 (en) Formulations of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methycyclohexylamino)-pyrimidine-5-carboxamide
TW202100517A (zh) 心肌肌鈣蛋白活化劑之多晶型物
TWI838482B (zh) 心肌肌鈣蛋白活化劑之多晶型物及共晶
EA028059B1 (ru) Твердые формы n-((s)-2,3-дигидроксипропил)-3-(2-фтор-4-йодфениламино)изоникотинамида
CN114349745B (zh) 一种用于治疗心肌缺血的药物及其制备方法
CN120676939A (zh) Pi3k抑制剂及其制备和使用方法
EA044681B1 (ru) Полиморфы и сокристаллы активатора кардиотропонина
CN101972240B (zh) 莫达芬尼组合物
WO2024164066A1 (en) Crystalline forms of acalabrutinib maleate
HK40068824A (en) Polymorphs and cocrystals of a cardiac troponin activator
WO2000027807A1 (en) Polymorphic forms of an amyloidosis inhibitor and methods of preparation
WO2025224069A1 (en) Co-crystals of finerenone, pecavaptan, and sglt2 inhibitors
US20160194281A1 (en) Crystalline forms of silodosin
HK40067758A (en) Compounds with ferroptosis inducing activity and methods of their use

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees